Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025

Rhea-AI Summary

Beta Bionics (Nasdaq: BBNX), a leader in advanced diabetes management solutions, will release its Q2 2025 financial results on Tuesday, July 29, 2025, after market close. The company will host a conference call and webcast at 4:30 PM ET on the same day.

Investors can access the webcast through the company's investor relations website under the "Events & Presentations" section, where it will also be archived for future viewing. For those joining by phone, registration is available through a dedicated link that will provide dial-in details and a personal pin.

[]

News Market Reaction

+1.43%

1 alert

+1.43% News Effect

On the day this news was published, BBNX gained 1.43%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second quarter 2025 financial results after the financial markets close on Tuesday, July 29, 2025. Management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time).

The link to the webcast will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay. To access the live call by phone, please use the following link, which will provide you with dial-in details and a personal pin: https://register-conf.media-server.com/register/BIc649100069fd4629a4ed5bf4826b8acb.

About Beta Bionics

Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.

Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com

Media and Public Relations:
Karen Hynes
Vice President of Marketing
media@betabionics.com

Source: Beta Bionics, Inc.

FAQ

When will Beta Bionics (BBNX) release Q2 2025 earnings?

Beta Bionics will release Q2 2025 earnings on Tuesday, July 29, 2025 after market close.

What time is the Beta Bionics (BBNX) Q2 2025 earnings call?

The earnings conference call and webcast will be held at 4:30 PM Eastern Time (1:30 PM Pacific Time) on July 29, 2025.

How can I access Beta Bionics (BBNX) Q2 2025 earnings call?

Investors can access the webcast through the company's website at investors.betabionics.com under 'Events & Presentations' section, or join by phone through the registration link.

Where can I find the replay of Beta Bionics (BBNX) Q2 2025 earnings call?

The earnings call replay will be archived in the 'Investors—Events & Presentations' section of Beta Bionics' website at investors.betabionics.com.